Medicare Enrolled

Dr. Nanda Nair, D.O.

Cardiovascular Disease · Oviedo, FL
Practice pattern: Cardiac Imaging— Practice with significant diagnostic imaging and stress testing
Low-engagement
1000 W BROADWAY ST STE 120, Oviedo, FL 32765
3218416444
In practice since 2011 (15 years)
NPI: 1265737126 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Nair from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Nair? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Nair

Dr. Nanda Nair is a cardiovascular disease in Oviedo, FL, with 15 years in practice. Based on federal Medicare data, Dr. Nair performed 2,824 Medicare services across 2,301 unique beneficiaries.

Between the years covered by Open Payments, Dr. Nair received a total of $2,155 from 27 pharmaceutical and/or device companies across 118 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Nair is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 15 years in practice▲ Top 43% volume in FL$ $2,155 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,824
Medicare services
Top 43% in FL for cardiovascular disease
2,301
Unique beneficiaries
$78
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~188 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
EKG interpretation and report490$6$20
Office visit, established patient (30-39 min)359$94$311
Hospital follow-up visit, high complexity289$94$257
Electrocardiogram (EKG), 12-lead189$10$35
Hospital follow-up visit, moderate complexity169$62$179
Regadenoson injection (Lexiscan) for heart stress test146$38$153
Technetium tc-99m tetrofosmin, diagnostic, per study dose128$340$1,092
Initial hospital admission, high complexity127$134$498
Echocardiogram, transthoracic122$137$475
New patient office visit (45-59 min)106$122$409
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician99$16$50
Exercise or drug-induced heart stress test with electrocardiogram (ecg)99$21$85
Nuclear medicine studies of heart muscle at rest and with stress and spect64$327$1,035
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician49$11$35
New patient office visit, complex (60-74 min)48$163$538
Initial hospital admission, moderate complexity45$103$433
Office visit, established patient (20-29 min)40$67$220
Injection, sulfur hexafluoride lipid microspheres, per ml40$14$589
Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional30$20$63
Office visit, established patient, complex (40-54 min)27$135$436
Ultrasound of heart with color-depicted blood flow, rate and valve function23$2$8
Ultrasound of heart, follow-up20$19$63
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician19$47$168
Office visit, established patient (10-19 min)18$40$162
Ultrasound of heart with probe in esophagus, with report15$83$271
Smoking and tobacco use intensive counseling, 4-10 minutes15$15$35
Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days13$17$58
Ultrasound of heart blood flow, valves and chambers12$14$45
Ultrasound of heart blood flow, valves and chambers, follow-up12$6$18
Heart rhythm recording continous external ekg over more than 48 hours up to 7 days11$8$28
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
6.0% high complexity
19.5% medium
74.5% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$2,155
Total received (2018-2024)
Avg $308/year across 7 years
Bottom 40% in FL for cardiovascular disease
27
Companies
118
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,072 (96.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$83 (3.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$403
2023
$127
2022
$64
2021
$146
2020
$102
2019
$716
2018
$598

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$559
Novartis Pharmaceuticals Corporation
$261
AstraZeneca Pharmaceuticals LP
$213
PFIZER INC.
$162
Janssen Pharmaceuticals, Inc
$113
Boehringer Ingelheim Pharmaceuticals, Inc.
$96
PORTOLA PHARMACEUTICALS, INC.
$76
Tepha Inc
$68
Medtronic Vascular, Inc.
$60
Amarin Pharma Inc.
$57
CHF Solutions, Inc
$55
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$51
SANOFI-AVENTIS U.S. LLC
$46
Gilead Sciences, Inc.
$42
Novo Nordisk Inc
$36
Alnylam Pharmaceuticals Inc.
$30
E.R. Squibb & Sons, L.L.C.
$28
Kiniksa Pharmaceuticals International, plc
$28
Boston Scientific Corporation
$25
Silk Road Medical, Inc.
$24
Esperion Therapeutics, Inc.
$21
Philips Electronics North America Corporation
$20
Astellas Pharma US Inc
$20
SCPHARMACEUTICALS INC.
$19
ARBOR PHARMACEUTICALS, INC.
$17
Lexicon Pharmaceuticals, Inc.
$15
Merck Sharp & Dohme Corporation
$15
Top 3 companies account for 47.9% of total payments
Associated products mentioned in payments ›
(5044) MCOT · 3F · ANDEXXA · Adapta · Aquadex · Arcalyst · BEVYXXA · BRILINTA · CAMZYOS · CHANTIX · Corlanor · ELIQUIS · ENROUTE Transcarotid Neuroprotection System · ENTRESTO · Edarbyclor · FARXIGA · FUROSCIX · GalaFLEX · JARDIANCE · LEQVIO · LEXISCAN · LifeVest · NEXLETOL · ONPATTRO · PRADAXA · PRALUENT · Repatha · Tresiba · VERQUVO · Vascepa · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $76 per 100 Medicare services performed
Looking for a cardiovascular disease in Oviedo?
Compare cardiovascular diseases in the Oviedo area by procedure volume, costs, and industry payment transparency.
Browse cardiovascular diseases nearby

Geographic Context

Cardiovascular Diseases within 10 mi
145
Per 100K population
30.5
County median income
$83,030
Nearest hospital
OVIEDO MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Nair is a cardiac imaging specialist, with moderate Medicare volume, and low-engagement industry engagement, with 15 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Nair experienced with ekg interpretation and report?
Based on Medicare claims data, Dr. Nair performed 490 ekg interpretation and report services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Nair receive payments from pharmaceutical companies?
Yes. Dr. Nair received a total of $2,155 from 27 companies across 118 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Nair's costs compare to other cardiovascular diseases in Oviedo?
Dr. Nair's average Medicare payment per service is $78. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Nair) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →